Quick Answer
Trulieve Cannabis Corp. reported Operating Income Loss of $143.50 million for the year ending 2025.
- Trulieve Cannabis Corp. showed an increase of +46.8% in Operating Income Loss from 2024 to 2025.
- This data is from Trulieve Cannabis Corp.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $42.51 million | Q2 2020: $52.48 million | Q3 2020: $59.47 million | Q1 2021: $72.56 million | Q2 2021: $76.30 million | Q3 2021: $66.28 million | Q1 2022: $29.17 million | Q2 2022: $41.47 million | Q3 2022: -$27.34 million | Q1 2023: $17.15 million | Q2 2023: -$291.29 million | Q3 2023: $23.34 million | Q1 2024: $46.10 million | Q2 2024: $49.75 million | Q3 2024: $618.0 thousand | Q1 2025: $33.33 million | Q2 2025: $52.63 million | Q3 2025: $42.24 million.
- Over the full 7 years of available data (2019 to 2025), Trulieve Cannabis Corp.'s Operating Income Loss has grown by 26.7%.
- Historical annual values: Fiscal year 2025: $143.50 million | Fiscal year 2024: $97.78 million | Fiscal year 2023: -$221.61 million | Fiscal year 2022: $50.17 million | Fiscal year 2021: $204.05 million | Fiscal year 2020: $218.30 million | Fiscal year 2019: $113.27 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: